Target selection and clinical chimeric antigen receptor T cell activity against solid tumors
Abstract Chimeric antigen receptor (CAR) T cell therapy is a relatively new form of targeted therapy that has demonstrated impressive success in treating hematological malignancies. It has been challenging to translate this success to solid tumors. Reasons for this include barriers to delivery, tumo...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2023-06-01
|
| Serija: | iLABMED |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/ila2.8 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|